Funding is always an issue with small biotechs - BIT is not alone there.
Remember that any partnerships or say, phase 3 trial funding will only cover the trial costs - not the company's general operations costs. Some costs can be massaged into the trial costs - some staff costs and so other minor costs. BIT will still need to raise cash for these operational costs.
BIT only has funds for the first quarter of 2024 - plus the $1mil tax rebate which will bet through a main part of the following quarter.
So financially, funding should be at the forefront of BT's management - and I suspect it is anyway.
- Forums
- ASX - By Stock
- BIT
- ETA for results
ETA for results, page-13
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
-0.009(32.1%) |
Mkt cap ! $16.24M |
Open | High | Low | Value | Volume |
2.2¢ | 2.5¢ | 1.8¢ | $312.3K | 15.52M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 2309324 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 3070882 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 1989324 | 0.018 |
20 | 6203823 | 0.017 |
14 | 1274362 | 0.016 |
13 | 1790895 | 0.015 |
3 | 586000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 846268 | 6 |
0.020 | 3025882 | 8 |
0.021 | 360000 | 4 |
0.022 | 388947 | 2 |
0.023 | 357187 | 3 |
Last trade - 14.28pm 06/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |